Patent · US Active

Anti-tumor antigen antibodies and methods of use

US9220772B2 · kind B2 · utility

11Cited by

1References

7Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Yu Zhou · Tempe, US
James D. Marks · Kensington, US

Key dates

Filing date	Jul 22, 2011
Grant date	Dec 29, 2015
Priority date	—
Expiry date	Oct 20, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies that bind to tumor associated antigen CD44 or to tumor associated antigen EphA2, are disclosed herein, as well as related compositions and methods of use. Methods of use encompass cancer therapies, diagnostics, and screening methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.